Indrayani Biotech
Indrayani Biotech Share Price Chart
Indrayani Biotech last traded at ₹8.77 (2026-10-13). Over the past month the stock moved -10.0%, three months the stock moved -15.3%, year the stock moved -29.3%. Its closing range over 52 weeks is ₹7.32 – ₹17.47, with the latest close 49.8% below the high.
Closing prices up to 2026-10-13.
About Indrayani Biotech
Incorporated in 1992, Indrayani Biotech Ltd is in the business of Foods & Hospitality, Engineering and Healthcare[1]
Business Overview:[1] IBL has multiple business units managed by an independent team of field experts. It operates in Food and Hospitality, Dairy, Healthcare & Pharma, Engineering, Biotech, Agriculture and Infrastructure
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Indrayani Biotech reported sales of ₹37.71 crore (+29.6%) and net profit of ₹0.54 crore (+237.5%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 37.71 | 1.46 | 3.87 | 0.54 | 0.07 |
| Mar 2026 | 37.76 | 2.22 | 5.88 | 0.98 | 0.13 |
| Dec 2025 | 35.01 | 2.79 | 7.97 | 0.12 | 0.02 |
| Sep 2025 | 35.95 | 2.45 | 6.82 | 0.91 | 0.05 |
| Jun 2025 | 29.10 | 2.18 | 7.49 | 0.16 | 0.02 |
| Mar 2025 | 50.57 | -5.74 | -11.35 | -8.53 | -1.09 |
| Dec 2024 | 17.32 | 2.92 | 16.86 | 0.35 | 0.03 |
| Sep 2024 | 30.81 | 5.11 | 16.59 | 1.22 | 0.16 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -23.8% | -55.7% | +13.9% | -7.7% | +16.7% | +102.1% | -25.3% | +29.6% |
| Operating profit growth | -29.9% | -15.4% | -156.4% | -63.5% | -52.1% | -4.5% | – | -33.0% |
| Net profit growth | -78.0% | -67.6% | -280.3% | -81.2% | -25.4% | -65.7% | – | +237.5% |
| EPS growth | -83.0% | -76.9% | -318.0% | -81.8% | -68.8% | -33.3% | – | +250.0% |
| OPM % | 16.6% | 16.9% | -11.4% | 7.5% | 6.8% | 8.0% | 5.9% | 3.9% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Indrayani Biotech reported sales of ₹138.00 crore (+6.2%) and net profit of ₹2.00 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 138.00 | 10.00 | 7.00 | 2.00 | 0.28 |
| Mar 2025 | 130.00 | 6.00 | 5.00 | -6.00 | -0.99 |
| Mar 2024 | 165.00 | 24.00 | 14.00 | 10.00 | 1.40 |
| Mar 2023 | 163.00 | 17.00 | 11.00 | 12.00 | 2.55 |
| Mar 2022 | 61.00 | 7.00 | 11.00 | 4.00 | 1.30 |
| Mar 2021 | 21.00 | -5.00 | -24.00 | -11.00 | -3.28 |
| Mar 2020 | 50.00 | 3.00 | 6.00 | 1.00 | 2.22 |
| Mar 2012 | 58.00 | 1.00 | 1.00 | 0.00 | -0.16 |
| Mar 2012 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +48.7% | -13.8% | -58.0% | +190.5% | +167.2% | +1.2% | -21.2% | +6.2% |
| Operating profit growth | +0.0% | +200.0% | -266.7% | – | +142.9% | +41.2% | -75.0% | +66.7% |
| Net profit growth | – | – | -1200.0% | – | +200.0% | -16.7% | -160.0% | – |
| EPS growth | – | – | -247.7% | – | +96.2% | -45.1% | -170.7% | – |
| OPM % | 1.0% | 6.0% | -24.0% | 11.0% | 11.0% | 14.0% | 5.0% | 7.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Indrayani Biotech.
Get Free AI Stock Analysis FREE →Latest News
-
Indrayani Biotech Q1FY27 Results: Standalone PAT up 13.5% YoY - scanx.trade
-
Indrayani Biotech sells 1.83% stake in subsidiary Dindigul Farm - scanx.trade
-
Indrayani Biotech sells 1.83% stake in subsidiary Dindigul Farm - scanx.trade
-
Indrayani Biotech sells 1.83% stake in subsidiary Dindigul Farm - scanx.trade
Frequently Asked Questions
What is the share price of Indrayani Biotech today?
Indrayani Biotech shares were last quoted at ₹8.77 (-4.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Indrayani Biotech?
Indrayani Biotech has a price-to-earnings (P/E) ratio of 32.38 and a price-to-book (P/B) ratio of 0.63. The industry P/E is 45.65.
What is the 52-week high and low of Indrayani Biotech?
The 52-week high of Indrayani Biotech is ₹16.47 and the 52-week low is ₹6.10.
What is the market cap of Indrayani Biotech?
The market capitalisation of Indrayani Biotech is about ₹55.60 crore.
How did Indrayani Biotech perform in its latest quarterly results?
In the latest quarter (Jun 2026), Indrayani Biotech reported sales of ₹37.71 crore (+29.6%) and net profit of ₹0.54 crore (+237.5%), compared with the same quarter last year.
Is Indrayani Biotech a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Indrayani Biotech has a 3-year ROE of 6.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Indrayani Biotech?
Promoters hold about 32.92% of Indrayani Biotech.
Which sector does Indrayani Biotech belong to?
Indrayani Biotech belongs to the other agriculture products sector.
Other other agriculture products stocks
All other agriculture products stocks · Browse all stocks A–Z